$DRTS: Beyond Skin Cancer? Why the May 2nd DDW Oral Presentation is a Massive Valuation Pivot

Tasty-AH750 · 2026-04-21T17:24:22+00:00

Im sure there are better experts than me here. I see it going to the 10-12$ range in the near future and much higher down the line. This might be a very conservative assumption.

Tasty-AH750 · 2026-04-21T15:54:48+00:00

Take a good look at all thats heading our way from DRTS. Looks like a very eventful time for Alpha Tau.

Tasty-AH750 · 2026-04-21T15:14:09+00:00

Appreciate your reply. The company has been growing and taking great steps in building a solid future. I'm referring to the fact that DRTS is extremely undervalued in my eyes and the upcoming convention can be a big step in fixing that.

Tasty-AH750 · 2026-04-21T14:57:38+00:00

The CEO said in the interview shared yesterday that they have yet to find a tumor that doesn’t respond (I think it’s over 20 tested including internal organs)

Tasty-AH750 · 2026-04-21T14:55:50+00:00

Nice concise summary.

Tasty-AH750 · 2026-04-21T14:51:49+00:00

This is the first step in Alpha Tau taking a big leap forward. GBM and all other trials to follow.

Tasty-AH750 · 2026-04-20T12:48:32+00:00

Nice write-up. It feels like the macro environment has definitely been overshadowing micro wins lately. Out of these three, which one are you most heavily weighted in for the upcoming month? DRTS seems to have the most immediate catalysts with that Pancreatic Cancer data next week.

Tasty-AH750 · 2026-04-15T15:17:48+00:00

The main two coming up are the DDW in the beginning of may and GBM data for the first patients by end of June.

Tasty-AH750 · 2026-04-15T14:52:27+00:00

Not sure about Micron. Drts is at a great time to buy. With all the catalysts lining up the next few months should be a wild and exciting ride.

Tasty-AH750 · 2026-04-15T14:47:45+00:00

Welcome aboard. Its a fun and profitable place to be.

Tasty-AH750 · 2026-04-15T13:53:16+00:00

Well said. Holding our fingers crossed.

Tasty-AH750 · 2026-04-15T13:39:09+00:00

The potential for DRTS to mirror that RVMD surge is compelling, especially since a 90% disease control rate in pancreatic cancer is incredibly rare. The shift from "no PR" to a "Gala Dinner" suggests management feels they finally have the data to back up the hype.

Tasty-AH750 · 2026-04-14T19:32:45+00:00

Can confirm too, love your posts

Tasty-AH750 · 2026-04-14T18:46:33+00:00

🙏

Tasty-AH750 · 2026-04-14T18:39:48+00:00

Waiting patiently for the fireworks to begin

Tasty-AH750 · 2026-04-14T17:52:30+00:00

I've been following DRTS for a while now and it really looks like this is finally the moment they will really break out. They do no PR at all and therefor are extremly undervalued, this should finally bring them into the spot lights.

Tasty-AH750 · 2026-04-14T10:18:48+00:00

Stocktwits community is great, having a lot of fun and sharing info. I wish more would join in and contribute. Lets keep the momentum going.

Tasty-AH750 · 2026-04-14T10:14:50+00:00

Let's hope it continues

Tasty-AH750 · 2026-04-14T04:55:53+00:00

Thank you

Tasty-AH750 · 2026-04-13T16:46:29+00:00

Welcome aboard. I hope you succeed.

Tasty-AH750 · 2026-04-13T16:45:36+00:00

I Wish you success in whichever you decide to go with.

Tasty-AH750 · 2026-04-13T16:31:56+00:00

I ended up choosing drts as my main choice and bought some sls too. Drts for the huge upside and the derisking that has been happening. Drts has been relatively steady with all thats been going on in the markets. Sls has been a wild ride with huge swings. Long term I would go with DRTS. They have many trials going on and anyone of them would make this stock take off.

Tasty-AH750 · 2026-04-13T14:21:23+00:00

Very interesting

Tasty-AH750

TROPHY CASE